NewsBot
11-21-2008, 11:10 PM
HealthDay - FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20081122/hl_hsn/adhdmedicationsdontposecancerrisk)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20081122/hl_hsn/adhdmedicationsdontposecancerrisk)
(From Yahoo Diseases)